×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PODD – insulet corporation (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PODD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/16
01:31 pm
podd
Abbott US diabetes device sales up 27% amid largely positive Q1 [Yahoo! Finance]
Low
Report
Abbott US diabetes device sales up 27% amid largely positive Q1 [Yahoo! Finance]
4/11
06:34 am
podd
The Week in Canadian Press Releases: 10 Stories You Need to See [Globe and Mail, The (Toronto, Canada)]
Low
Report
The Week in Canadian Press Releases: 10 Stories You Need to See [Globe and Mail, The (Toronto, Canada)]
4/7
01:45 pm
podd
This Insulin Pump Maker Expands Into New Territory And Its Stock Shows Relative Strength [Yahoo! Finance]
Low
Report
This Insulin Pump Maker Expands Into New Territory And Its Stock Shows Relative Strength [Yahoo! Finance]
4/3
06:00 am
podd
Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025
Low
Report
Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025
3/27
07:53 am
podd
3 Reasons Investors Love Insulet (PODD) [Yahoo! Finance]
Low
Report
3 Reasons Investors Love Insulet (PODD) [Yahoo! Finance]
3/21
06:46 am
podd
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers [Yahoo! Finance]
Low
Report
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers [Yahoo! Finance]
3/19
04:08 pm
podd
Insulet's RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections [Yahoo! Finance]
Low
Report
Insulet's RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections [Yahoo! Finance]
3/19
04:01 pm
podd
Insulet’s RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections
Low
Report
Insulet’s RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/9
04:09 pm
podd
Form 8-K/A INSULET CORP For: Mar 14
Medium
Report
Form 8-K/A INSULET CORP For: Mar 14
3/26
04:22 pm
podd
Form 4 INSULET CORP For: Mar 25 Filed by: Frederick Wayne A.I.
Low
Report
Form 4 INSULET CORP For: Mar 25 Filed by: Frederick Wayne A.I.
3/25
10:30 am
podd
Form 144 INSULET CORP Filed by: Frederick Wayne A.I.
Low
Report
Form 144 INSULET CORP Filed by: Frederick Wayne A.I.
3/21
07:55 am
podd
Form 8-K INSULET CORP For: Mar 20
Low
Report
Form 8-K INSULET CORP For: Mar 20
3/18
05:11 pm
podd
Form 8-K INSULET CORP For: Mar 18
Low
Report
Form 8-K INSULET CORP For: Mar 18
3/18
07:49 am
podd
Form 8-K INSULET CORP For: Mar 18
Low
Report
Form 8-K INSULET CORP For: Mar 18
3/17
05:06 pm
podd
Form 8-K INSULET CORP For: Mar 14
Low
Report
Form 8-K INSULET CORP For: Mar 14
3/10
06:35 am
podd
Form 8-K INSULET CORP For: Mar 07
Medium
Report
Form 8-K INSULET CORP For: Mar 07
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/5
Insulet Reports Second Quarter 2019 Revenue of $177 Million, an Increase of 43% Year-Over-Year
21.4%
11/5 Form 8-K INSULET CORP For: Nov 05 10.5%
9/3 Form 8-K INSULET CORP For: Sep 03 9.4%
5/6 Insulet Co. (NASDAQ: PODD) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $115.00 price target on the stock. 5.4%
2/26 Diabetes Stock Insulet Drops 8.5% on Earnings Miss and Softer-Than-Expected Outlook [The Motley Fool] 4.4%
4/6 Insulet to Announce First Quarter 2020 Financial Results on May 7, 2020 4.2%
1/6 Insulet to Announce Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020 3.7%
9/24 Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Svb Leerink Llc from $160.00 to $185.00. They now have an "outperform" rating on the stock. 3.5%
2/26 Insulet Co. (NASDAQ: PODD) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $205.00 price target on the stock, down previously from $213.00. 3.5%
2/27 Form 4 INSULET CORP For: Feb 26 Filed by: Benjamin Eric 3.4%
11/5 Form 8-K INSULET CORP For: Nov 05 10.5%
9/3 Form 8-K INSULET CORP For: Sep 03 9.4%
5/6 Insulet Co. (NASDAQ: PODD) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $115.00 price target on the stock. 5.4%
2/26 Diabetes Stock Insulet Drops 8.5% on Earnings Miss and Softer-Than-Expected Outlook [The Motley Fool] 4.4%
4/6 Insulet to Announce First Quarter 2020 Financial Results on May 7, 2020 4.2%
1/6 Insulet to Announce Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020 3.7%
9/24 Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Svb Leerink Llc from $160.00 to $185.00. They now have an "outperform" rating on the stock. 3.5%
2/26 Insulet Co. (NASDAQ: PODD) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $205.00 price target on the stock, down previously from $213.00. 3.5%
2/27 Form 4 INSULET CORP For: Feb 26 Filed by: Benjamin Eric 3.4%
TOP News Decliners
2/25
Q4/2019 12/31/2019 EPS 0.080 ZacksConsensus 0.090 ActVsEst (0.010) - Miss
-8.5%
10/22 Insulet Co. (NASDAQ: PODD) is now covered by analysts at Stifel Nicolaus. They set a "hold" rating on the stock. -8.4%
7/31 Form 8-K INSULET CORP For: Jul 31 -5.7%
2/24 Form 4 INSULET CORP For: Feb 21 Filed by: Spears Michael P -5.1%
3/31 Insulet Co. (NASDAQ: PODD) was downgraded by analysts at Berenberg Bank from a "buy" rating to a "hold" rating. -5.0%
3/10 Form 4 INSULET CORP For: Mar 06 Filed by: Lemoine David A -4.7%
3/2 Insulet Provides Update on Pivotal Study of Omnipod Horizon™ -4.5%
3/2 Form 4 INSULET CORP For: Feb 27 Filed by: Spears Michael P -4.0%
9/4 Insulet prices upsized convertible debt offering [Seeking Alpha] -3.8%
4/6 Why Diabetes Stock Insulet Fell 13% in March [The Motley Fool] -3.6%
10/22 Insulet Co. (NASDAQ: PODD) is now covered by analysts at Stifel Nicolaus. They set a "hold" rating on the stock. -8.4%
7/31 Form 8-K INSULET CORP For: Jul 31 -5.7%
2/24 Form 4 INSULET CORP For: Feb 21 Filed by: Spears Michael P -5.1%
3/31 Insulet Co. (NASDAQ: PODD) was downgraded by analysts at Berenberg Bank from a "buy" rating to a "hold" rating. -5.0%
3/10 Form 4 INSULET CORP For: Mar 06 Filed by: Lemoine David A -4.7%
3/2 Insulet Provides Update on Pivotal Study of Omnipod Horizon™ -4.5%
3/2 Form 4 INSULET CORP For: Feb 27 Filed by: Spears Michael P -4.0%
9/4 Insulet prices upsized convertible debt offering [Seeking Alpha] -3.8%
4/6 Why Diabetes Stock Insulet Fell 13% in March [The Motley Fool] -3.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: